Our findings imply that CR1*2‐expressing astrocytes may be more efficient eliminators of synapses, potentially enhancing neurodegeneration in AD; future work will assess the impact of expression of the CR1 variants on synaptic elimination by microglia and astrocytes utilizing in vitro and ex vivo models. This evidence concerns the gene CR1 and Alzheimer disease.